Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Gemtesa® (vibegron) – New drug approval
December 23, 2020 - Urovant Sciences announced the FDA approval of Gemtesa (vibegron), for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adults.
